drugset / Trial / NCT00409019

Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy

NCT00409019 ↗

Phase 4 Withdrawn Novartis Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to find out if taking a combination of telbivudine and adefovir or tenofovir and telbivudine can lower the amount of Hepatitis B virus in patients that have been taking adefovir alone for at least 5 months and have had less than optimal responses. The safety of taking telbivudine and adefovir together or tenofovir and telbivudine together will also be studied.

Timeline

Start
—
Primary completion
2011-03
Completion
—

Outcome

Outcome not reported

Stopped (Enrollment): “Study cancelled: Withdrawn before enrollment of any participants”

Drugs

EvaluationDrugModalityDoseRoute
Subject Adefovir Unknown — —
Subject Telbivudine Small molecule — —
Subject Tenofovir Small molecule — —